CD19 Recombinant Protein from ProteoGenix; catalogue PX-P4077; research use only.
Know who made it. See the evidence. Buy through one marketplace.
CD19 is a transmembrane glycoprotein expressed on the surface of B cells. It is composed of two extracellular immunoglobulin-like domains and a short cytoplasmic tail.
CD19 Recombinant Protein ActivityCD19 plays an important role in the development and function of B cells by mediating signal transduction and cell adhesion. It also interacts with other immune checkpoint proteins to regulate B cell survival, differentiation and activation.
CD19 Recombinant Protein ApplicationCD19 is an attractive target for antibody-drug conjugates (ADCs) due to its broad expression on B cells. It has been used in clinical trials for the treatment of B cell malignancies such as leukemia and lymphoma.
ProteoGenix catalogue number PX-P4077. For research use only.
Host: Mammalian cells; Expression system: Eukaryotic expression; Purity: >90% by SDS-PAGE; Molecular weight: 45kDa; Tag: C-terminal His Tag; Fragment: Met1~Trp290; Buffer: PBS pH7.5; Applications: ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
